Gelstat Stock

Gelstat Current Liabilities

The Current Liabilities of Gelstat (GSAC) as of Sep 8, 2026 is 735,446.00 USD. In the previous year, Current Liabilities was 994,192.00 USD — a change of -26.03% (lower).

Current Liabilities

735,446.00USD

YoY

-26.03%

Last updated:

Current Liabilities of Gelstat is 2026 735,446.00 USD. Current Liabilities of Gelstat was 2025 994,192.00 USD. It decreases by -26.03% lower compared to the previous year.

The Gelstat Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2018
20,172.00 USD
Jan 1, 2019
68,752.00 USD
Jan 1, 2020
421,945.00 USD
Jan 1, 2021
707,138.00 USD
Jan 1, 2022
824,549.00 USD
Jan 1, 2023
446,878.00 USD
Jan 1, 2024
994,192.00 USD
Jan 1, 2025
735,446.00 USD
The Gelstat Current Liabilities history
YEARCurrent LiabilitiesYoY
735,446.00USD-26.03%
994,192.00USD+122.48%
446,878.00USD-45.80%
824,549.00USD+16.60%
707,138.00USD+67.59%
421,945.00USD+513.72%
68,752.00USD+240.83%
20,172.00USD-98.53%
1.37 MUSD+554.92%
209,741.00USD-82.62%
1.21 MUSD+81.08%
666,326.00USD
0.00USD-100.00%
6,400.00USD-99.71%
2.23 MUSD+7.86%
2.07 MUSD+16.25%
1.78 MUSD+6.59%
1.67 MUSD+11.90%
1.49 MUSD+301.89%
371,350.00USD+717.77%
45,410.00USD-83.40%
273,513.00USD+74.10%
157,103.00USD-47.43%
298,839.00USD-54.14%
651,697.00USD-30.78%
941,496.00USD0.00%
941,496.00USD
Access this data via the Eulerpool API

Gelstat Stock analysis

What does Gelstat do? The Gelstat Corporation is a US-American company specializing in the production of pharmaceuticals and complementary preparations. The development and marketing of products that improve well-being and health is at the center of the company's business model. The Gelstat Corporation was founded in 2004 by Dr. Thomas Smith and Dr. David Knopman. Originally, the company focused on the development of methods for the diagnosis of degenerative brain diseases. In collaboration with renowned research institutions and universities, the Gelstat Corporation was able to achieve valuable achievements in this field. In 2008, the company expanded its portfolio and began producing medications and dietary supplements. The Gelstat Corporation focused particularly on the use of ingredients that have positive effects on the body and well-being according to scientific studies. Currently, the company is divided into two main divisions: Gelstat Migraine and Gelstat Sleep. Gelstat Migraine is an over-the-counter preparation used for pain relief in migraine attacks. The product contains a high concentration of magnesium and therefore does not cause side effects such as nausea or dizziness that can occur with many other pain relievers. The use of Gelstat Migraine in combination with other medications is also safe. Gelstat Sleep is a dietary supplement taken to improve sleep quality. It contains a combination of plant-based ingredients such as valerian, passionflower, and melatonin. These active ingredients have a calming effect and can help to fall asleep and stay asleep more quickly. Gelstat Sleep is free of chemical substances and therefore suitable for long-term use. In addition to the two main divisions, Gelstat Corporation also offers other products based on natural ingredients. These include dietary supplements to strengthen the immune system, products for joint discomfort, and for improving memory performance. The goal of Gelstat Corporation is to promote the health and well-being of people in a natural way. The company ensures that all production steps are carried out under strict quality controls. The product development is also based on scientific studies and done in close collaboration with experts in the respective field. In summary, the Gelstat Corporation is an innovative company specializing in the production of pharmaceuticals and complementary preparations. The company's products are based on natural ingredients and have positive effects on the well-being and health of people. Through close collaboration with experts and strict adherence to quality standards, Gelstat Corporation has quickly made a name for itself in the industry. Gelstat is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Gelstat stock

Current Liabilities of Gelstat is 735,446.00 USD in 2026.

Current Liabilities of Gelstat changed from 994,192.00 USD to 735,446.00 USD, representing a -26.03% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Gelstat since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Gelstat historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Gelstat

All Key Metrics — Gelstat